MASON, Ohio--(BUSINESS WIRE)--Oct. 4, 2016--
AtriCure, Inc. (Nasdaq:ATRC), a leading innovator in treatments for
atrial fibrillation (Afib) and left atrial appendage management, will
release its financial results for the third quarter of 2016 on Thursday,
October 27, 2016.
AtriCure will host a conference call at 4:30 p.m. Eastern Time on
Thursday, October 27, 2016 to discuss its third quarter 2016 financial
results. The call may be accessed through an operator by calling (844)
884-9951 for domestic callers and (661) 378-9661 for international
callers using conference ID number 91346855. A live webcast of the
conference call will be available online on the Investor page of
AtriCure’s corporate website at www.atricure.com.
A replay of the webcast will be available for 90 days following the call.
About AtriCure, Inc.
AtriCure, Inc. is a medical device company providing innovative atrial
fibrillation (Afib) solutions designed to produce superior outcomes that
reduce the economic and social burden of atrial fibrillation. AtriCure’s
Synergy™ Ablation System is the first and only surgical device approved
for the treatment of persistent and longstanding persistent forms of
Afib in patients undergoing certain open concomitant procedures.
AtriCure’s AtriClip® left atrial appendage management (LAAM) exclusion
device is the most widely sold device worldwide that is indicated for
the occlusion of the left atrial appendage. The company believes
cardiothoracic surgeons are adopting its ablation and LAAM devices for
the treatment of Afib and reduction of Afib related complications such
as stroke. AtriCure recently acquired nContact, a leader in minimally
invasive technology for epicardial ablation. nContact’s mission is to
transform the underserved arrhythmia population through a
multidisciplinary epicardial-endocardial ablation approach. Afib affects
more than 33 million people worldwide. For more information, visit AtriCure.com
or follow us on Twitter @AtriCure.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161004005819/en/
Source: AtriCure, Inc.
Andy Wade, 513-755-4564
President and Chief Financial Officer
Lynn Pieper, 415-309-5999